Of these patients , 3060 had tumour MGMT status tested ; 926 patients had a methylated MGMT promoter , and 545 were randomly assigned to the cilengitide ( n = 272 ) or control groups ( n = 273 ) between Oct 31 , 2008 , and May 12 , 2011 .